Kathryn Maitland1, Sarah Kiguli1, Peter Olupot-Olupot1, Charles Engoru1, Macpherson Mallewa1, Pedro Saramago Goncalves1, Robert O Opoka1, Ayub Mpoya1, Florence Alaroker1, Julius Nteziyaremye1, George Chagaluka1, Neil Kennedy1, Eva Nabawanuka1, Margaret Nakuya1, Cate Namayanja1, Sophie Uyoga1, Dorothy Kyeyune Byabazaire1, Bridon M'baya1, Benjamin Wabwire1, Gary Frost1, Imelda Bates1, Jennifer A Evans1, Thomas N Williams1, Elizabeth C George1, Diana M Gibb1, A Sarah Walker1. 1. From the Department of Pediatrics (K.M., T.N.W.) and Nutrition Research Section (G.F.), Imperial College London, and the Medical Research Council Clinical Trials Unit at University College London (E.C.G., D.M.G., A.S.W.), London, the Centre for Health Economics, University of York, York (P.S.G.), the School of Medicine, Dentistry, and Biomedical Science, Queen's University, Belfast (N.K.), Liverpool School of Tropical Medicine and Hygiene, Liverpool (I.B.), and the Department of Pediatrics, University Hospital of Wales, Cardiff (J.A.E.) - all in the United Kingdom; the Department of Pediatrics, Makerere University and Mulago Hospital (S.K., R.O.O., E.N.), and the Uganda Blood Transfusion Services (BTS), National BTS (D.K.B.), Kampala, Busitema University Faculty of Health Sciences, Mbale Campus and Mbale Regional Referral Hospital (P.O.-O., J.N., C.N.), and Mbale BTS (B.W.), Mbale, and the Soroti Regional Referral Hospital, Soroti (C.E., F.A., M.N.) - all in Uganda; the College of Medicine and Malawi-Liverpool-Wellcome Trust Clinical Research Program (M.M., G.C.). and Malawi BTS (B.M.), Blantyre, Malawi; and the Kenya Medical Research Institute-Wellcome Trust Research Program, Kilifi, Kenya (K.M., A.M. S.U., T.N.W.).
Abstract
BACKGROUND: The World Health Organization recommends not performing transfusions in African children hospitalized for uncomplicated severe anemia (hemoglobin level of 4 to 6 g per deciliter and no signs of clinical severity). However, high mortality and readmission rates suggest that less restrictive transfusion strategies might improve outcomes. METHODS: In this factorial, open-label, randomized, controlled trial, we assigned Ugandanand Malawian children 2 months to 12 years of age with uncomplicated severe anemia to immediate transfusion with 20 ml or 30 ml of whole-blood equivalent per kilogram of body weight, as determined in a second simultaneous randomization, or no immediate transfusion (control group), in whichtransfusion with 20 ml of whole-blood equivalent per kilogram was triggered by new signs of clinical severity or a drop in hemoglobin to below 4 g per deciliter. The primary outcome was 28-day mortality. Three other randomizations investigated transfusion volume, postdischarge supplementation with micronutrients, and postdischarge prophylaxis with trimethoprim-sulfamethoxazole. RESULTS: A total of 1565 children (median age, 26 months) underwent randomization, with 778 assigned to the immediate-transfusion group and 787 to the control group; 984 children (62.9%) had malaria. The children were followed for 180 days, and 71 (4.5%) were lost to follow-up. During the primary hospitalization, transfusion was performed in all the children in the immediate-transfusion group and in 386 (49.0%) in the control group (median time to transfusion, 1.3 hours vs. 24.9 hours after randomization). The mean (±SD) total blood volume transfused per child was 314±228 ml in the immediate-transfusion group and 142±224 ml in the control group. Death had occurred by 28 days in 7 children (0.9%) in the immediate-transfusion group and in 13 (1.7%) in the control group (hazard ratio, 0.54; 95% confidence interval [CI], 0.22 to 1.36; P = 0.19) and by 180 days in 35 (4.5%) and 47 (6.0%), respectively (hazard ratio, 0.75; 95% CI, 0.48 to 1.15), without evidence of interaction with other randomizations (P>0.20) or evidence of between-group differences in readmissions, serious adverse events, or hemoglobin recovery at 180 days. The mean length of hospital stay was 0.9 days longer in the control group. CONCLUSIONS: There was no evidence of differences in clinical outcomes over 6 months between the children who received immediate transfusion and those who did not. The triggered-transfusion strategy in the control group resulted in lower blood use; however, the length of hospital stay was longer, and this strategy required clinical and hemoglobin monitoring. (Funded by the Medical Research Council and Department for International Development; TRACT Current Controlled Trials number, ISRCTN84086586.).
RCT Entities:
BACKGROUND: The World Health Organization recommends not performing transfusions in African children hospitalized for uncomplicated severe anemia (hemoglobin level of 4 to 6 g per deciliter and no signs of clinical severity). However, high mortality and readmission rates suggest that less restrictive transfusion strategies might improve outcomes. METHODS: In this factorial, open-label, randomized, controlled trial, we assigned Ugandan and Malawian children 2 months to 12 years of age with uncomplicated severe anemia to immediate transfusion with 20 ml or 30 ml of whole-blood equivalent per kilogram of body weight, as determined in a second simultaneous randomization, or no immediate transfusion (control group), in which transfusion with 20 ml of whole-blood equivalent per kilogram was triggered by new signs of clinical severity or a drop in hemoglobin to below 4 g per deciliter. The primary outcome was 28-day mortality. Three other randomizations investigated transfusion volume, postdischarge supplementation with micronutrients, and postdischarge prophylaxis with trimethoprim-sulfamethoxazole. RESULTS: A total of 1565 children (median age, 26 months) underwent randomization, with 778 assigned to the immediate-transfusion group and 787 to the control group; 984 children (62.9%) had malaria. The children were followed for 180 days, and 71 (4.5%) were lost to follow-up. During the primary hospitalization, transfusion was performed in all the children in the immediate-transfusion group and in 386 (49.0%) in the control group (median time to transfusion, 1.3 hours vs. 24.9 hours after randomization). The mean (±SD) total blood volume transfused per child was 314±228 ml in the immediate-transfusion group and 142±224 ml in the control group. Death had occurred by 28 days in 7 children (0.9%) in the immediate-transfusion group and in 13 (1.7%) in the control group (hazard ratio, 0.54; 95% confidence interval [CI], 0.22 to 1.36; P = 0.19) and by 180 days in 35 (4.5%) and 47 (6.0%), respectively (hazard ratio, 0.75; 95% CI, 0.48 to 1.15), without evidence of interaction with other randomizations (P>0.20) or evidence of between-group differences in readmissions, serious adverse events, or hemoglobin recovery at 180 days. The mean length of hospital stay was 0.9 days longer in the control group. CONCLUSIONS: There was no evidence of differences in clinical outcomes over 6 months between the children who received immediate transfusion and those who did not. The triggered-transfusion strategy in the control group resulted in lower blood use; however, the length of hospital stay was longer, and this strategy required clinical and hemoglobin monitoring. (Funded by the Medical Research Council and Department for International Development; TRACT Current Controlled Trials number, ISRCTN84086586.).
Authors: Jacques Lacroix; Paul C Hébert; James S Hutchison; Heather A Hume; Marisa Tucci; Thierry Ducruet; France Gauvin; Jean-Paul Collet; Baruch J Toledano; Pierre Robillard; Ari Joffe; Dominique Biarent; Kathleen Meert; Mark J Peters Journal: N Engl J Med Date: 2007-04-19 Impact factor: 91.245
Authors: Job C J Calis; Kamija S Phiri; E Brian Faragher; Bernard J Brabin; Imelda Bates; Luis E Cuevas; Rob J de Haan; Ajib I Phiri; Pelani Malange; Mirriam Khoka; Paul J M Hulshof; Lisette van Lieshout; Marcel G H M Beld; Yik Y Teo; Kirk A Rockett; Anna Richardson; Dominic P Kwiatkowski; Malcolm E Molyneux; Michaël Boele van Hensbroek Journal: N Engl J Med Date: 2008-02-28 Impact factor: 91.245
Authors: Kathryn Maitland; Peter Olupot-Olupot; Sarah Kiguli; George Chagaluka; Florence Alaroker; Robert O Opoka; Ayub Mpoya; Charles Engoru; Julius Nteziyaremye; Macpherson Mallewa; Neil Kennedy; Margaret Nakuya; Cate Namayanja; Julianna Kayaga; Sophie Uyoga; Dorothy Kyeyune Byabazaire; Bridon M'baya; Benjamin Wabwire; Gary Frost; Imelda Bates; Jennifer A Evans; Thomas N Williams; Pedro Saramago Goncalves; Elizabeth C George; Diana M Gibb; A Sarah Walker Journal: N Engl J Med Date: 2019-08-01 Impact factor: 91.245
Authors: Ayub Mpoya; Sarah Kiguli; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Macpherson Mallewa; Yami Chimalizeni; Neil Kennedy; Dorothy Kyeyune; Benjamin Wabwire; Bridon M'baya; Imelda Bates; Britta Urban; Michael Boele von Hensbroek; Robert Heyderman; Margaret J Thomason; Sophie Uyoga; Thomas N Williams; Diana M Gibb; Elizabeth C George; A Sarah Walker; Kathryn Maitland Journal: Trials Date: 2015-12-29 Impact factor: 2.279
Authors: Fereydoun Ala; Jean-Pierre Allain; Imelda Bates; Kamel Boukef; Frank Boulton; James Brandful; Elizabeth M Dax; Magdy El Ekiaby; Albert Farrugia; Jed Gorlin; Oliver Hassall; Helen Lee; André Loua; Kathryn Maitland; Dora Mbanya; Zainab Mukhtar; William Murphy; Ohene Opare-Sem; Shirley Owusu-Ofori; Henk Reesink; David Roberts; Oscar Torres; Grace Totoe; Henrik Ullum; Silvano Wendel Journal: PLoS Med Date: 2012-09-11 Impact factor: 11.069
Authors: Kamija S Phiri; Job C J Calis; Brian Faragher; Ernest Nkhoma; Kondwani Ng'oma; Bridget Mangochi; Malcolm E Molyneux; Michaël Boele van Hensbroek Journal: PLoS One Date: 2008-08-06 Impact factor: 3.240
Authors: Sarah Kiguli; Kathryn Maitland; Elizabeth C George; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Samuel O Akech; Richard Nyeko; George Mtove; Hugh Reyburn; Michael Levin; Abdel G Babiker; Diana M Gibb; Jane Crawley Journal: BMC Med Date: 2015-02-02 Impact factor: 11.150
Authors: Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert Journal: Cochrane Database Syst Rev Date: 2021-12-21
Authors: Kathryn Maitland; Peter Olupot-Olupot; Sarah Kiguli; George Chagaluka; Florence Alaroker; Robert O Opoka; Ayub Mpoya; Charles Engoru; Julius Nteziyaremye; Macpherson Mallewa; Neil Kennedy; Margaret Nakuya; Cate Namayanja; Julianna Kayaga; Sophie Uyoga; Dorothy Kyeyune Byabazaire; Bridon M'baya; Benjamin Wabwire; Gary Frost; Imelda Bates; Jennifer A Evans; Thomas N Williams; Pedro Saramago Goncalves; Elizabeth C George; Diana M Gibb; A Sarah Walker Journal: N Engl J Med Date: 2019-08-01 Impact factor: 91.245
Authors: Elizabeth M Keating; Msandeni Chiume; Elizabeth Fitzgerald; Yamikani Mgusha; Tisungane Mvalo; Nora Fino; Heather L Crouse; Michelle Eckerle; Kathleen Gorman; Emily J Ciccone; Gladstone Airewele; Jeff A Robison Journal: Paediatr Int Child Health Date: 2021-04-19 Impact factor: 1.990
Authors: Titus K Kwambai; Aggrey Dhabangi; Richard Idro; Robert Opoka; Victoria Watson; Simon Kariuki; Nickline A Kuya; Eric D Onyango; Kephas Otieno; Aaron M Samuels; Meghna R Desai; Michael Boele van Hensbroek; Duolao Wang; Chandy C John; Bjarne Robberstad; Kamija S Phiri; Feiko O Ter Kuile Journal: N Engl J Med Date: 2020-12-03 Impact factor: 176.079
Authors: Hans Ackerman; Aintzane Ayestaran; Christopher H O Olola; Muminatou Jallow; Tsiri Agbenyega; Kalifa Bojang; David J Roberts; Sanjeev Krishna; Peter G Kremsner; Charles R Newton; Terrie Taylor; Clarissa Valim; Climent Casals-Pascual Journal: Lancet Haematol Date: 2020-11 Impact factor: 18.959